Results 41 to 50 of about 2,830,257 (398)

Is psychiatric morbidity in chronic migraine associated with poor outcome: Experience from a tertiary care centrer

open access: yesIndustrial Psychiatry Journal, 2020
Introduction: Chronic Migraine is defined as headache occurring on 15 or more days/month for more than 3 months, which, on at least 8 days/month, has the features of migraine headache.
Vikas Mathur   +4 more
doaj   +1 more source

Depression is not the only cause of cognitive impairment in chronic migraine

open access: yesНервно-мышечные болезни, 2019
Background. Patients with the chronic migraine frequently present with memory and attention complaints. However, the prevalence and phenotype of such impairment in chronic migraine have not been studied.Objective – to evaluate the prevalence of the ...
N. V. Latysheva   +2 more
doaj   +1 more source

Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review

open access: yesHeadache, 2020
To review the literature on the mechanism of action of onabotulinumtoxinA in chronic migraine.
R. Burstein   +4 more
semanticscholar   +1 more source

Current and emerging evidence-based treatment options in chronic migraine: a narrative review

open access: yesThe Journal of Headache and Pain, 2019
Background Chronic migraine is a disabling condition that is currently underdiagnosed and undertreated. In this narrative review, we discuss the future of chronic migraine management in relation to recent progress in evidence-based pharmacological ...
Elio Clemente Agostoni   +15 more
doaj   +1 more source

Induction of chronic migraine phenotypes in a rat model after environmental irritant exposure [PDF]

open access: yes, 2017
Air pollution is linked to increased emergency department visits for headache and migraine patients frequently cite chemicals or odors as headache triggers, but the association between air pollutants and headache is not well understood.
Hurley, Joyce Harts   +4 more
core   +1 more source

Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience

open access: yesThe Journal of Headache and Pain, 2020
Background erenumab was safe and effective in clinical trials for the prevention of migraine. However, real-life data are still lacking. Here we report the clinical experience from an Italian real-world setting using erenumab in patients with chronic ...
A. Russo   +7 more
semanticscholar   +1 more source

Associations between stress and migraine and tension-type headache: Results from a school-based study in adolescents from grammar schools in Germany [PDF]

open access: yes, 2011
Introduction: Stress is considered the major contributor to migraine and tension-type headache in adolescents. Previous studies have focused on general stressors, whereas the aim of the present study was to investigate associations between individuals ...
Blaschek, Astrid   +7 more
core   +1 more source

Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review

open access: yesLife, 2023
Chronic pain conditions have a high socio-economic impact and represent a burden for patients, and their management is a challenge for healthcare professionals.
Délia Szok   +3 more
doaj   +1 more source

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine [PDF]

open access: yes, 2018
Migraine remains one of the biggest clinical case to be solved among the non-communicable diseases, second to low back pain for disability caused as reported by the Global Burden of Disease Study 2016.
Martelletti, Paolo
core   +1 more source

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

open access: yesHeadache, 2021
To evaluate the efficacy of fremanezumab in patients with chronic migraine (CM) and moderate to severe depression.
R. Lipton   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy